The effect of BMI on the median effective doses of dexmedetomidine for colonoscopy

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100050813

Enrollment

Unknown

Registered

2021-09-04

Start date

2021-09-05

Completion date

Unknown

Last updated

2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Interventions

High BMI group:No

Medium BMI group:No

Low BMI group :No

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade was I-II; 2. Aged 18 to 64 years; 3. Patients with elective colonoscopy.

Exclusion criteria

Exclusion criteria: 1. Severe abnormalities in heart, lung, kidney, liver, and other functions; 2. Recent respiratory infections; 3. History of allergies to narcotic drugs; 4. Mental illness.

Design outcomes

Primary

Measure	Time frame
Median effective dose;	—

Secondary

Measure	Time frame
Mean arterial pressure (MAP);Heart rate (HR);Respiratory rate (RR);SpO2;Bispectral index (BIS);	—

Countries

China

Contacts

Public ContactJia Li

The Fourth Hospital of Hebei Medical University

281575038@qq.com+86 13933089766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026